Insys Ch. 11 Sales For Two Drug Lines Approved In Del.
Bankrupt pharmaceutical company Insys Therapeutics received court approval Thursday in Delaware for a pair of asset sales that will transfer certain drug lines in deals worth more than $29 million....To view the full article, register now.
Already a subscriber? Click here to view full article